Vitro Biopharma, Inc. (VTRO)
Vitro Biopharma will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$5.00 - $6.00
Shares Offered
1,000,000
Deal Size
$5.50M
Vitro Biopharma Revenue
Vitro Biopharma had revenue of $3.07M in the twelve months ending April 30, 2022. In the fiscal year ending October 31, 2021, Vitro Biopharma had annual revenue of $1.31M with 102.09% growth.
Revenue (ttm)
$3.07M
Revenue Growth
+102.09%
P/S Ratio
19.78
Revenue / Employee
$169,740
Employees
12
Market Cap
40.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2021 | 1.31M | 662.24K | 102.09% |
| Oct 31, 2020 | 648.71K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionVTRO News
- 2 years ago - IPO Update: Vitro Biopharma Aims For $10 Million U.S. IPO - Seeking Alpha
- 3 years ago - Vitro Biopharma IPO Registration Document (S-1) - SEC